Pneumonia hospitalisation and case-fatality rates in older Australians with and without risk factors for pneumococcal disease: implications for vaccine policy
Dirmesropian, S, Liu, B, Wood, J G, MacIntyre, C R, McIntyre, P, Karki, S, Jayasinghe, S, Newall, A T
Published in Epidemiology and infection (01.01.2019)
Published in Epidemiology and infection (01.01.2019)
Get full text
Journal Article
Cost-effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) in older Australians
Dirmesropian, S., Wood, J.G., MacIntyre, C.R., Beutels, P., McIntyre, P., Menzies, R., Reyes, J.F., Chen, C., Newall, A.T.
Published in Vaccine (03.08.2017)
Published in Vaccine (03.08.2017)
Get full text
Journal Article
The role of timeliness in the cost-effectiveness of older adult vaccination: A case study of pneumococcal conjugate vaccine in Australia
Chen, C., Wood, J.G., Beutels, P., Menzies, R., MacIntyre, C.R., Dirmesropian, S., Reyes, J.F., McIntyre, P., Newall, A.T.
Published in Vaccine (28.02.2018)
Published in Vaccine (28.02.2018)
Get full text
Journal Article